Rossi G A, Sacco O, Cosulich E, Damiani G, Corte G, Bargellesi A, Ravazzoni C
Thorax. 1984 Feb;39(2):143-9. doi: 10.1136/thx.39.2.143.
Different lymphocyte subpopulations have been evaluated in bronchoalveolar fluid and blood obtained from six patients with active and six with inactive pulmonary sarcoidosis and from six normal subjects by means of two recently described monoclonal antibodies, 5/9 and MLR4. The percentages of OKT4 positive (helper) and OKT8 positive (suppressor) T cells were also determined. Patients with active sarcoidosis had significantly higher proportions of 5/9 positive T cells in the bronchoalveolar fluid than patients with inactive disease (p less than 0.01) or normal subjects (p less than 0.001). In contrast, the proportions of 5/9 positive blood T cells were similar in the three groups studied. Patients with active sarcoidosis had also a greater proportion proportion of MLR4 positive T lymphocytes in bronchoalveolar fluid than patients with inactive disease or normal subjects (p less than 0.01 for each comparison), but similar proportions of MLR4 positive blood T cells were found in each group. The ratio of 5/9 positive to MLR4 positive T cells was higher in the bronchoalveolar fluid (but not in the blood) in patients with either active or inactive sarcoidosis than in normal subjects. These observations suggest that the MLR4 negative fraction rather than the MLR4 positive fraction of the 5/9 positive T cells is preferentially expanded in the lungs of patients with pulmonary sarcoidosis and may indicate a secondary role for the MLR4 positive T cells in producing lung injury in this disorder. Comparisons of the OKT4 positive and 5/9 positive T cells showed that in patients with active disease most of the lung T lymphocytes expressed both the OKT4 and the 5/9 surface antigens, so the 5/9 monoclonal antibody may be considered a good marker of activity in this disorder. Pulmonary sarcoidosis may be characterised by the preferential expansion of helper T cell subsets at sites of disease activity.
通过两种最近描述的单克隆抗体5/9和MLR4,对6例活动期肺结节病患者、6例非活动期肺结节病患者以及6名正常受试者的支气管肺泡灌洗液和血液中的不同淋巴细胞亚群进行了评估。同时还测定了OKT4阳性(辅助性)和OKT8阳性(抑制性)T细胞的百分比。活动期结节病患者支气管肺泡灌洗液中5/9阳性T细胞的比例显著高于非活动期疾病患者(p<0.01)或正常受试者(p<0.001)。相比之下,在所研究的三组中,血液中5/9阳性T细胞的比例相似。活动期结节病患者支气管肺泡灌洗液中MLR4阳性T淋巴细胞的比例也高于非活动期疾病患者或正常受试者(每次比较p<0.01),但每组中血液中MLR4阳性T细胞的比例相似。活动期或非活动期结节病患者支气管肺泡灌洗液中(而非血液中)5/9阳性与MLR4阳性T细胞的比例高于正常受试者。这些观察结果表明,在肺结节病患者的肺中,5/9阳性T细胞的MLR4阴性部分而非MLR4阳性部分优先扩增,这可能表明MLR4阳性T细胞在该疾病中产生肺损伤方面起次要作用。对OKT4阳性和5/9阳性T细胞的比较显示,在活动期疾病患者中,大多数肺T淋巴细胞同时表达OKT4和5/9表面抗原,因此5/9单克隆抗体可被视为该疾病活动的良好标志物。肺结节病的特征可能是在疾病活动部位辅助性T细胞亚群优先扩增。